MERCURY NEUROTOXICITY - MECHANISMS OF BLOOD-BRAIN-BARRIER TRANSPORT

被引:273
作者
ASCHNER, M
ASCHNER, JL
机构
[1] UNION UNIV,INTERDISCIPLINARY NEUROSCI PROGRAM,ALBANY,NY 12208
[2] UNION UNIV,DEPT PEDIAT,DIV NEONATAL MED,ALBANY,NY 12208
关键词
Blood-brain barrier; Mercury; Methylmercury; Neurotoxicity; Neutral amino acid; Transport;
D O I
10.1016/S0149-7634(05)80217-9
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Mercury exists in a wide variety of physical and chemical states, each of which has unique characteristics of target organ toxicity. The classic symptoms associated with exposure to elemental mercury vapor (Hg0) and methylmercury (Ch3Hg+; MeHg) involve the central nervous system (CNS), while the kidney is the target organ for the mono- and divalent salts of mercury (Hg+ and Hg++, respectively). Physical properties and redox potentials determine the qualitative and quantitative differences in toxicity among inorganic mercury compounds, while the ability of MeHg to cross the blood-brain barrier accounts for its accumulation in the CNS and a clinical picture that is dominated by neurological disturbances. This review gives an up-to-date account of mercury's physical and chemical properties and its interaction with biologically active sites pertinent to transport across the blood-brain barrier, a major regulator of the CNS millieu. © 1990 Pergamon Press plc.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 109 条
[22]  
CARTY AJ, 1979, BIOGEOCHEMISTRY MERC, P433
[23]   EXPERIMENTAL METHYL MERCURY NEUROTOXICITY - SIMILAR INVIVO AND INVITRO PERTURBATION OF BRAIN CELL-FREE PROTEIN-SYNTHESIS [J].
CHEUNG, MK ;
VERITY, MA .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1983, 38 (02) :230-242
[24]   ON THE STRATEGY OF KINETIC DISCRIMINATION OF AMINO-ACID TRANSPORT-SYSTEMS [J].
CHRISTENSEN, HN .
JOURNAL OF MEMBRANE BIOLOGY, 1985, 84 (02) :97-103
[25]   ORGANIC ION-TRANSPORT DURING 7 DECADES - THE AMINO-ACIDS [J].
CHRISTENSEN, HN .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 779 (03) :255-269
[26]   PHARMACOLOGY OF MERCURY-COMPOUNDS [J].
CLARKSON, TW .
ANNUAL REVIEW OF PHARMACOLOGY, 1972, 12 :375-+
[27]  
Ehrlich P, 1906, COLLECTED STUDIES IM, P567
[28]  
ELEY BP, 1983, J PHYSIOL-LONDON, V342, pP71
[29]  
FANELLI GM, 1972, J PHARMACOL EXP THER, V180, P759
[30]  
Fedoroff S, 1986, ASTROCYTES DEV MORPH, V1